|
시장보고서
상품코드
2054678
심장 트로포닌 시장 : 트로포닌 유형별, 제품 유형, 검사 형식별, 샘플 유형별, 측정 감도별, 기술 플랫폼별, 임상 용도별, 검사 소요 시간별, 연령층별, 최종사용자별, 유통 채널별, 지역별Cardiac Troponin Market, By Troponin Type, By Product Type, By Test Format, By Sample Type, By Assay Sensitivity, By Technology Platform, By Clinical Application, By Turnaround Time, By Age Group, By End User, By Distribution Channel, By Geography |
||||||
심장 트로포닌 시장은 2026년에 48억 7,000만 달러로 추정되고 있으며, 2033년까지 98억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 10.5%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 48억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 10.50% | 2033년 시장 규모 예측 : | 98억 달러 |
전 세계 심장 트로포닌 시장은 심혈관 진단 업계의 중요한 부문으로, 급성 심근경색 진단 및 심장 치료 관리에 혁신을 가져온 바이오마커 검사에 중점을 두고 있습니다.
심장 트로포닌, 특히 트로포닌 I(cTnI) 및 트로포닌 T(cTnT)는 심근 세포가 손상되었을 때 혈류로 방출되는 고감도·고특이성의 단백질 바이오마커로, 심근경색 및 기타 급성 관상동맥 증후군의 진단에 있으며, 표준 검사로 자리 잡고 있습니다.
이 시장에는 고감도 트로포닌 측정법, 현장 진단 기기, 그리고 심장 질환을 신속하고 정확하게 감지할 수 있는 실험실 기반 면역 분석 시스템 등 다양한 검사 기법이 포함됩니다. 전 세계 심혈관 질환의 부담 증가, 고령화, 그리고 조기 심장 중재술에 대한 의식의 향상에 따라 심장 트로포닌 검사 시장은 인상적인 성장과 기술적 진보를 이루고 있습니다.
전 세계의 의료진은 중요한 임상적 판단을 내리고, 환자의 사망률을 낮추며, 치료 프로토콜을 최적화하기 위해 이러한 진단 툴에 의존하고 있습니다. 이 시장은 응급실과 중환자실부터 외래 진료소, 진단 검사실에 이르기까지 다양한 의료 현장에 대응하고 있으며, 전 세계 선진국 및 신흥 국가의 의료 시장에서 급성기 치료와 일상적인 심장 모니터링을 모두 지원하고 있습니다.
시장 역학
전 세계 심장 트로포닌 시장은 주로 전 세계 심혈관 질환 유병률의 급증에 힘입어 성장하고 있습니다. 심혈관 질환은 여전히 전 세계 주요 사망 원인 중 하나로, 매년 수백만 명에게 영향을 미치며 정확한 진단 솔루션에 대한 막대한 수요를 창출하고 있습니다.
고령화는 시장 성장에 크게 기여하고 있습니다. 고령자는 심장 질환 발생 위험이 높기 때문에 빈번한 모니터링과 조기 발견 능력이 요구됩니다. 고감도 트로포닌 검사 기술의 발전은 진단 정확도에 혁명을 가져왔으며, 극히 미미한 수준의 심근 손상을 감지할 수 있게 해줄 뿐만 아니라, 환자의 예후를 개선하는 조기 중재 전략을 촉진하고 있습니다.
응급실 및 중환자실에서 현장 검사 장비의 도입이 확대됨에 따라 신속한 결과 제공을 통해 임상적 의사결정 과정을 가속화하며 시장 성장을 주도하고 있습니다. 그러나 시장에는 첨단 트로포닌 검사 장비나 시약과 관련된 높은 비용이라는 일정한 제약이 존재하며, 이는 자원이 제한된 의료 시설이나 개발도상 지역에서의 도입을 제한할 가능성이 있습니다. 진단 기기 승인과 관련된 엄격한 규제 요건은 제품 출시를 지연시키고, 개발 비용을 증가시키며, 시장 성장을 저해할 우려가 있습니다.
특정 환자 집단에서 나타나는 위양성 결과나 다양한 병증에 의한 간섭은 검사의 신뢰성이나 의사의 확신에 영향을 미칠 수 있는 임상적 과제로 대두되고 있습니다. 그럼에도 불구하고 신흥 시장, 특히 아시아태평양과 라틴아메리카의 의료 인프라 확충을 통해 큰 성장 기회가 존재합니다. 이러한 지역에서는 의료 투자 증가와 심장 건강에 대한 의식의 향상가 큰 성장 가능성을 열어주고 있습니다. 특이도와 민감도를 향상시킨 차세대 트로포닌 검사법의 개발은 시장에서 차별화와 프리미엄 포지셔닝의 기회를 제공합니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음 매개변수를 바탕으로 전 세계 심장 트로포닌 시장의 주요 기업을 분석하고 있습니다. : 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 이 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계 심장 트로포닌 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계 심장 트로포닌 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 심장 트로포닌 시장 : 트로포닌 유형별, 2021-2033년
제5장 세계의 심장 트로포닌 시장 : 제품 유형별, 2021-2033년
제6장 세계의 심장 트로포닌 시장 : 검사 형식별, 2021-2033년
제7장 세계의 심장 트로포닌 시장 : 샘플 유형별, 2021-2033년
제8장 세계의 심장 트로포닌 시장 : 측정 감도별, 2021-2033년
제9장 세계의 심장 트로포닌 시장 : 기술 플랫폼별, 2021-2033년
제10장 세계의 심장 트로포닌 시장 : 임상 용도별, 2021-2033년
제11장 세계의 심장 트로포닌 시장 : 검사 소요 시간별, 2021-2033년
제12장 세계의 심장 트로포닌 시장 : 연령층별, 2021-2033년
제13장 세계의 심장 트로포닌 시장 : 최종사용자별, 2021-2033년
제14장 세계의 심장 트로포닌 시장 : 유통 채널별, 2021-2033년
제15장 세계의 심장 트로포닌 시장 : 지역별, 2021-2033년
제16장 경쟁 구도
제17장 애널리스트의 제안
제18장 참고 문헌 및 조사 방법
KSA 26.06.17Cardiac Troponin Market is estimated to be valued at USD 4.87 Bn in 2026 and is expected to reach USD 9.80 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.87 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.50% | 2033 Value Projection: | USD 9.80 Bn |
The global cardiac troponin market represents a critical segment within the cardiovascular diagnostic industry, focusing on biomarker testing that has revolutionized acute myocardial infarction diagnosis and cardiac care management.
Cardiac troponins, specifically troponin I (cTnI) and troponin T (cTnT), are highly sensitive and specific protein biomarkers released into the bloodstream when cardiac muscle cells are damaged, making them the gold standard for diagnosing heart attacks and other acute coronary syndromes.
The market encompasses various testing methodologies including high-sensitivity troponin assays, point-of-care testing devices, and laboratory-based immunoassay systems that enable rapid and accurate detection of cardiac events. With the increasing global burden of cardiovascular diseases, aging populations, and rising awareness about early cardiac intervention, the cardiac troponin testing market has experienced substantial growth and technological advancement.
Healthcare providers worldwide rely on these diagnostic tools to make critical clinical decisions, reduce patient mortality rates, and optimize treatment protocols. The market serves diverse healthcare settings from emergency departments and intensive care units to outpatient clinics and diagnostic laboratories, supporting both acute care scenarios and routine cardiac monitoring applications across developed and emerging healthcare markets globally.
Market Dynamics
The global cardiac troponin market is primarily driven by the escalating prevalence of cardiovascular diseases worldwide, which remains the leading cause of mortality globally, affecting millions annually and creating substantial demand for accurate diagnostic solutions.
The aging population demographic significantly contributes to market growth as elderly individuals face higher risks of cardiac events, necessitating frequent monitoring and early detection capabilities. Technological advancements in high-sensitivity troponin assays have revolutionized diagnostic precision, enabling detection of even minute levels of cardiac damage and facilitating earlier intervention strategies that improve patient outcomes.
The growing adoption of point-of-care testing devices in emergency departments and critical care settings drives market expansion by providing rapid results that accelerate clinical decision-making processes. However, the market faces certain restraints including high costs associated with advanced troponin testing equipment and reagents, which may limit adoption in resource-constrained healthcare facilities and developing regions. Stringent regulatory requirements for diagnostic device approvals can delay product launches and increase development costs, potentially hindering market growth.
False positive results in certain patient populations and interference from various medical conditions pose clinical challenges that may affect test reliability and physician confidence. Nevertheless, significant opportunities exist through expanding healthcare infrastructure in emerging markets, particularly in Asia Pacific and Latin America, where increasing healthcare investments and rising awareness about cardiac health create substantial growth potential. The development of next-generation troponin assays with enhanced specificity and sensitivity presents opportunities for market differentiation and premium positioning.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cardiac troponin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Beckman Coulter, bioMerieux, Ortho Clinical Diagnostics, Danaher Corporation, QuidelOrtho, Thermo Fisher Scientific, Sysmex Corporation, DiaSorin, Fujirebio, Randox Laboratories, Tosoh Bioscience, and Snibe Diagnostic
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cardiac troponin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac troponin market
Market Segmentation
- Troponin Type Insights (Revenue, USD Bn, 2021 - 2033)
- Cardiac Troponin I (cTnI)
- Cardiac Troponin T (cTnT)
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Reagents and Kits
- Calibrators and Controls
- Consumables and Accessories
- Test Format Insights (Revenue, USD Bn, 2021 - 2033)
- Laboratory-Based Troponin Tests
- Point-of-Care (POC) Troponin Tests
- Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
- Whole Blood
- Serum
- Plasma
- Assay Sensitivity Insights (Revenue, USD Bn, 2021 - 2033)
- Conventional/Standard Sensitivity Troponin Assays
- High-Sensitivity Troponin Assays (hs-cTn)
- Technology Platform Insights (Revenue, USD Bn, 2021 - 2033)
- Chemiluminescence Immunoassays (CLIA)
- Enzyme-Linked Immunosorbent Assays (ELISA)
- Fluorescence Immunoassays
- Immunochromatographic Assays
- Electrochemical Immunoassays
- Other immunoassay methods
- Clinical Application Insights (Revenue, USD Bn, 2021 - 2033)
- Acute Myocardial Infarction (AMI) Diagnosis
- Acute Coronary Syndrome (ACS) Risk Stratification
- Myocardial Injury Monitoring (Non-AMI Causes)
- Prognostic and Outcome Assessment
- Turnaround Time Insights (Revenue, USD Bn, 2021 - 2033)
- Rapid Tests (<30 minutes)
- Standard Tests (≥30 minutes)
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Adult Population
- Geriatric Population
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Diagnostic Laboratories
- Emergency Care Centers
- Cardiac Specialty Clinics
- Ambulatory Care Centers
- Research and Academic Institutes
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Online
- Offline
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Beckman Coulter
- bioMerieux
- Ortho Clinical Diagnostics
- Danaher Corporation
- QuidelOrtho
- Thermo Fisher Scientific
- Sysmex Corporation
- DiaSorin
- Fujirebio
- Randox Laboratories
- Tosoh Bioscience
- Snibe Diagnostic
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cardiac Troponin Market, By Troponin Type
- Global Cardiac Troponin Market, By Product Type
- Global Cardiac Troponin Market, By Test Format
- Global Cardiac Troponin Market, By Sample Type
- Global Cardiac Troponin Market, By Assay Sensitivity
- Global Cardiac Troponin Market, By Technology Platform
- Global Cardiac Troponin Market, By Clinical Application
- Global Cardiac Troponin Market, By Turnaround Time
- Global Cardiac Troponin Market, By Age Group
- Global Cardiac Troponin Market, By End User
- Global Cardiac Troponin Market, By Distribution Channel
- Global Cardiac Troponin Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Cardiac Troponin Market, By Troponin Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cardiac Troponin I (cTnI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiac Troponin T (cTnT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Cardiac Troponin Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Reagents and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Calibrators and Controls
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Consumables and Accessories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Cardiac Troponin Market, By Test Format, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Laboratory-Based Troponin Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Point-of-Care (POC) Troponin Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Cardiac Troponin Market, By Sample Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Whole Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Serum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Cardiac Troponin Market, By Assay Sensitivity, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Conventional/Standard Sensitivity Troponin Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- High-Sensitivity Troponin Assays (hs-cTn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Cardiac Troponin Market, By Technology Platform, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Chemiluminescence Immunoassays (CLIA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Enzyme-Linked Immunosorbent Assays (ELISA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fluorescence Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunochromatographic Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Electrochemical Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other immunoassay methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Cardiac Troponin Market, By Clinical Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Acute Myocardial Infarction (AMI) Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Acute Coronary Syndrome (ACS) Risk Stratification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Myocardial Injury Monitoring (Non-AMI Causes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Prognostic and Outcome Assessment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Cardiac Troponin Market, By Turnaround Time, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Rapid Tests (<30 minutes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Standard Tests (≥30 minutes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
12. Global Cardiac Troponin Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adult Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
13. Global Cardiac Troponin Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Emergency Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiac Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
14. Global Cardiac Troponin Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
15. Global Cardiac Troponin Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Troponin Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Assay Sensitivity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Turnaround Time, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Troponin Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Assay Sensitivity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Turnaround Time, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Troponin Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Assay Sensitivity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Turnaround Time, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Troponin Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Assay Sensitivity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Turnaround Time, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Troponin Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Assay Sensitivity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Turnaround Time, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Troponin Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Assay Sensitivity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Turnaround Time, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
16. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beckman Coulter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ortho Clinical Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QuidelOrtho
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DiaSorin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujirebio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Randox Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tosoh Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Snibe Diagnostic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
17. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
18. References and Research Methodology
- References
- Research Methodology
- About us
